Calendar of Events & Lectures

Today
This Week

Monday, May 15, 2017

Using the Cell Cycle to Treat Cancer

| ZUCKERMAN AUDITORIUM, MSKCC, 417 E. 68TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Norman Sharpless, M.D., Wellcome Distinguished Professor of Medicine and Genetics, director, UNC Lineberger Comprehensive Cancer Center, University of North Carolina

Thymic Selection of Soldiers and Peacekeepers

| ZUCKERMAN AUDITORIUM, MSKCC, 417 E. 68TH ST.
Tri-Institutional Events (at MSK & WCM), Other Tri-Institutional Events
Kristin Hogquist, Ph.D., professor, department of laboratory medicine and pathology, associate director, Center for Immunology, University of Minnesota

Harnessing Host Immunity against HIV: The Function of Antiretroviral Antibodies in the Course of HIV Infection

| CASPARY AUDITORIUM
Academic Lectures, Thesis Presentations
Ching-Lan Lu, graduate student, The Rockefeller University

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Microscale Biophysics of the Ocean: A Single-Cell Perspective on the Biological Carbon Pump

| CARSON FAMILY AUDITORIUM (CRC)

Liquid Biopsies in Pediatric Solid Tumors

| CARSON FAMILY AUDITORIUM (CRC)

Spying on the Immune System

| CASPARY AUDITORIUM
The Philip Levine Memorial Lecture

News

Some mammals can hit pause on a pregnancy. Understanding how that happens could help us treat cancer.

New study reveals the molecular brake that lets embryonic stem cells enter suspended animation, while retaining the ability to develop normally—which could shed light on abnormal cell growth in humans.

New engineered derivative of a natural molecule could translate into a powerful replacement for IVIG therapy for a wide array of autoimmune disorders

In experiments with mice, the new molecule accomplished the same job at a hundredth of the dose.

This new insight into T cell receptors may improve cancer immunotherapies

Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.

Room Reservation Calendar